Triall today announces that it has officially partnered with Dizer Capital, a private equity firm focused on startups in the technology sector. The investment provided by Dizer Capital will enable...Read More
Allan Bukuya has joined the Triall initiative as Advisor eClinical Solutions. He brings two decades of experience in clinical research and in-depth understanding of the Pharma, CRO and eClinical industries....Read More
Danielle Bradbury will join the Triall initiative as advisor Quality and Compliance. She has over 20 years of experience in clinical research and has extensive knowledge of SOP management, GxP...Read More
Sina Djali will join the ranks of the Triall initiative as advisor Clinical Trial Data Analytics. Sina has over 25 years of experience in drug and clinical development in various...Read More
We are excited to announce the world’s first clinical trial on the blockchain. A beta version of the foundation’s Verial software application was given green light for use in a real-world...Read More
Triall today announces that it has received funding as part of the second Factom grant round of 2019. It will use these funds to develop a Factom-enabled Decentralized Identifier (DID)...Read More
Triall today announces that it will be presenting at the ClinOpsDag 2019 (‘Clinical Operations Day’) event on the 15th of May. As part of the event, Joost Flach, Triall’s director...Read More
Triall announces the official release of the Triall whitepaper. This document outlines the foundation’s vision and plans for building towards the world’s first multisided clinical trial platform that is open to...Read More
Triall today announces that it has been awarded a Seal of Excellence by the European Commission (EC) as the institution managing Horizon 2020, the EU Framework Program for Research and...Read More
Triall today announces that it has been featured in a video explaining the Factom Asset Token protocol (FAT). FAT is an open-source tokenization protocol build on top of the Factom...Read More
